Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 42, 2020 - Issue 2
319
Views
9
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH PAPER

Cognitive functions in pediatric multiple sclerosis: 2-years follow-up

, ORCID Icon, ORCID Icon, , , & show all
Pages 159-163 | Received 29 Jul 2019, Accepted 12 Dec 2019, Published online: 08 Jan 2020

References

  • Banwell B, Ghezzi A, Bar-Or A, et al. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol. 2007;6(10):887–902.
  • Rao SM. Neuropsychology of multiple sclerosis. Curr Opin Neurol. 1995;8(3):216–220.
  • MacAllister WS, Belman AL, Milazzo M, et al. Cognitive functioning in children and adolescents with multiple sclerosis. Neurology. 2005;64(8):1422–1425.
  • Banwell BL, Anderson PE. The cognitive burden of multiple sclerosis in children. Neurology. 2005;64(5):891–894.
  • Amato MP, Goretti B, Ghezzi A, et al. Neuropsychological features in childhood and juvenile multiple sclerosis: five-year follow-up. Neurology. 2014;83(16):1432–1438.
  • Amato MP, Goretti B, Ghezzi A, et al. Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. Neurology. 2010;75(13):1134–1140.
  • Amato MP, Krupp LB, Charvet LE, et al. Pediatric multiple sclerosis: cognition and mood. Neurology. 2016;87(9 Suppl 2):S82–7.
  • Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008;7(12):1139–1151.
  • Amato MP, Goretti B, Ghezzi A, et al. Cognitive and psychosocial features of childhood and juvenile MS. Neurology. 2008;70(20):1891–1897.
  • Krupp LB, Tardieu M, Amato MP, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. 2013;19(10):1261–1267.
  • Jozwiak S, Veggiotti P, Moreira J, et al. Effects of adjunctive eslicarbazepine acetate on neurocognitive functioning in children with refractory focal-onset seizures. Epilepsy Behav. 2018;81:1–11.
  • Şahin N, Düzen E, editors. Turkish standardization of the Raven’s SPM (6-15 Ages). 23rd International Congress of applied Psychology; 1993; Madrid, Spain.
  • Gencpinar P, Kalay Z, Turgut S, et al. Evaluation of executive functions in patients with childhood absence epilepsy. J Child Neurol. 2016;31(7):824–830.
  • Bekci B, Karakas S. Perceptual conflict and response competition: event-related potentials of the stroop effect. Turk Psikiyatri Derg. 2009;20(2):127–137.
  • Starowicz-Filip A, Chrobak AA, Milczarek O, et al. The visuospatial functions in children after cerebellar low-grade astrocytoma surgery: a contribution to the pediatric neuropsychology of the cerebellum. J Neuropsychol. 2017;11(2):201–221.
  • Karakas S, Dincer E. Bilnot Bataryasi Çocuk El Kitabi: Nöropsikolojik testler için araştirma ve geliştirme çalismalari. Ankara (Turkey): Nobel Tip Kitapevleri; 2011.
  • Öktem Ö. Nöropsikolojik testler ve nöropsikolojik değerlendirme. Türk Psikoloji Dergisi. 1994;9(33):33–44.
  • Amato MP, Bartolozzi ML, Zipoli V, et al. Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology. 2004;63(1):89–93.
  • Amato MP, Portaccio E, Goretti B, et al. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. Arch Neurol. 2007;64(8):1157–1161.
  • Johnston MV. Plasticity in the developing brain: implications for rehabilitation. Dev Disabil Res Rev. 2009;15(2):94–101.
  • Fischer JS, Priore RL, Jacobs LD, et al. Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Ann Neurol. 2000;48(6):885–892.
  • Kappos L, Freedman MS, Polman CH, et al. Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol. 2009;8(11):987–997.
  • MacAllister WS, Christodoulou C, Milazzo M, et al. Longitudinal neuropsychological assessment in pediatric multiple sclerosis. Dev Neuropsychol. 2007;32(2):625–644.
  • Till C, Racine N, Araujo D, et al. Changes in cognitive performance over a 1-year period in children and adolescents with multiple sclerosis. Neuropsychology. 2013;27(2):210–219.
  • Charvet LE, O’Donnell EH, Belman AL, et al. Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network. Mult Scler. 2014;20(11):1502–1510.
  • Suppiej A, Cainelli E. Cognitive dysfunction in pediatric multiple sclerosis. Neuropsychiatr Dis Treat. 2014;10:1385–1392.
  • Wuerfel E, Weddige A, Hagmayer Y, et al. Cognitive deficits including executive functioning in relation to clinical parameters in paediatric MS patients. PLoS One. 2018;13(3):e0194873.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.